Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.8749
-0.0401 (-4.38%)
At close: Aug 29, 2025, 4:00 PM
0.8875
+0.0126 (1.44%)
After-hours: Aug 29, 2025, 7:59 PM EDT
Predictive Oncology Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Predictive Oncology.
Price Target: $ (0.00%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Predictive Oncology is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +242.90% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +11,329.88% | Jun 30, 2021 |
Financial Forecast
Revenue This Year
9.52M
from 1.62M
Increased by 486.27%
Revenue Next Year
15.76M
from 9.52M
Increased by 65.50%
EPS This Year
-0.13
from -2.32
EPS Next Year
0.08
from -0.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.8M | 16.2M | |
| Avg | 9.5M | 15.8M | |
| Low | 9.1M | 15.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 503.5% | 70.4% | |
| Avg | 486.3% | 65.5% | |
| Low | 463.2% | 59.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.14 | 0.08 | |
| Avg | -0.13 | 0.08 | |
| Low | -0.13 | 0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.